Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2021 Q1- Text added to 2021 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Good
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Good
|
New words:
age, antitrust, atrophy, attribution, Biden, billion, bioresearch, blinded, cap, Carlo, CDR, Circuit, consummation, cortex, curve, customary, dismissing, durable, elevating, enlargement, freeze, FTLD, GENFI, Glaxo, GlaxoSmithKline, GSK, HSR, jointly, longitudinal, matched, matching, midpoint, monoclonal, Monte, month, MRI, NACC, peer, persist, plc, propensity, refined, remote, requisite, Rescue, resurgence, SB, score, simulation, standing, subsidiary, Treasury, twelve, ventricular, Volumetric, weight, Wellcome
Valuein 2021 Q1 filing- Value in 2021 Q2 filing
Original filings
Filing view